DocTIS’ Results Presented at EULAR 2024

Results DocTIS EULAR

Dr. Alejandro Gómez from Rheumatology Research Group at Vall d’Hebron Institut de Recerca and Dr. José Luis Andreu, Head of Rheumatology at Hospital Universitario Puerta del Hierro in Madrid, attended the European Congress of Rheumatology in Vienna to present findings from the DocTIS project.

They showcased the poster titled “Single Cell RNA-Seq Characterization of Circulating Immune Cells in Sjögren’s Syndrome: Comparison to SLE and Rheumatoid Arthritis”, which highlighted single-cell data from patients with Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE), collected through the DocTIS project. The study explored both common and specific biological pathways in Sjögren’s Syndrome, a chronic autoimmune disorder where the immune system attacks moisture-producing glands in the eyes, mouth, and other body parts. The DocTIS data on SLE and RA proved crucial in identifying meaningful, translatable targets.

The European Congress of Rheumatology 2024 was held in Vienna from June 12-15. Organized annually by the European Alliance of Associations for Rheumatology (EULAR), it is one of the world’s leading international conferences in the field of rheumatology.

DocTIS’s Results Presented at EULAR 2024